The animal vaccines market has witnessed significant growth and diversification in recent years, with different segments gaining prominence. In 2022, the livestock segment emerged as the dominant market, capturing the highest revenue share. This can be attributed to several factors, including the increasing population of livestock, supportive government initiatives, and the prevalence of diseases among cattle and sheep. To combat E. coli infections in livestock, vaccines such as Aviguard and Nobilis E. coli inac, developed by Merck & Co., Inc., have been instrumental.
The livestock segment emerged as the dominant market in 2022, capturing the highest revenue share in Veterinary Vaccines Market. This can be attributed to various factors such as the increasing population of livestock, supportive government initiatives, and the occurrence of diseases among cattle and sheep. Vaccines like Aviguard and Nobilis E. coli inac, developed by Merck & Co., Inc., are designed to prevent E. coli infections. According to Zoetis, the prevalence rate of E. coli in different cattle categories, including feedlot cattle, cattle on irrigated pasture, cattle at slaughter, and cattle grazing rangeland forages, ranges from 0.2% to 27.8%.
On the other hand, the companion segment is expected to exhibit the highest growth rate during the forecast period. Canine distemper virus is carried by house pets, ferrets, and other animals, and preventive vaccination is crucial as there is no post-infection treatment available. The Morbillivirus, which causes distemper in dogs, foxes, raccoons, and wolves, is transmitted through the air and other modes of contact between infected and healthy animals. Vaccination of dogs against canine distemper is essential as the virus can damage the respiratory, urogenital, and gastrointestinal tracts. Vanguard, DHPPi/L Vaccine, DHP, and Megavac 6 and 7 are some of the available canine distemper vaccines in the Veterinary Vaccines Market.
Read More: https://cmi-reports.blogspot.com/2023/06/key-players-technological-advancements.html
